{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:14:26Z","timestamp":1777389266940,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1038\/7268","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:45:45Z","timestamp":1027673145000},"page":"358-363","source":"Crossref","is-referenced-by-count":652,"title":["Dopamine activation of endogenous cannabinoid signaling in dorsal striatum"],"prefix":"10.1038","volume":"2","author":[{"given":"A.","family":"Giuffrida","sequence":"first","affiliation":[]},{"given":"L. H.","family":"Parsons","sequence":"additional","affiliation":[]},{"given":"T. M.","family":"Kerr","sequence":"additional","affiliation":[]},{"given":"F. Rodr\u00edguez","family":"de Fonseca","sequence":"additional","affiliation":[]},{"given":"M.","family":"Navarro","sequence":"additional","affiliation":[]},{"given":"D.","family":"Piomelli","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnn0499_358_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev.ne.15.030192.001441","volume":"15","author":"CR Gerfen","year":"1992","unstructured":"Gerfen, C. R. The neostriatal mosaic: multiple levels of compartmental organization. Annu. Rev. Neurosci. 15, 285\u2013320 (1992).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnn0499_358_CR2","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1126\/science.8091209","volume":"265","author":"AM Graybiel","year":"1994","unstructured":"Graybiel, A. M., Aosaki, T., Flaherty, A. W. & Kimura, M. The basal ganglia and adaptive motor control. Science 265, 1826\u20131831 (1994).","journal-title":"Science"},{"key":"BFnn0499_358_CR3","first-page":"497","volume":"69","author":"TN Chase","year":"1996","unstructured":"Chase, T. N., Engber, T. M. & Mouradian, M. M. Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease. Adv. Neurol. 69, 497\u2013501 (1996).","journal-title":"Adv. Neurol."},{"key":"BFnn0499_358_CR4","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","volume":"273","author":"SS Wolf","year":"1996","unstructured":"Wolf, S. S. et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273, 1225\u20131227 (1996).","journal-title":"Science"},{"key":"BFnn0499_358_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1212\/WNL.48.4.927","volume":"48","author":"D Eidelberg","year":"1997","unstructured":"Eidelberg, D. et al. The metabolic anatomy of Tourette's syndrome. Neurology 48, 927\u2013934 (1997).","journal-title":"Neurology"},{"key":"BFnn0499_358_CR6","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham, M. et al. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87, 1932\u20131936 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn0499_358_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda, L. A., Lolait, S. J., Brownstein, M., Young, A. & Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561\u2013564 (1990).","journal-title":"Nature"},{"key":"BFnn0499_358_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham, M. et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563\u2013583 (1991).","journal-title":"J. Neurosci."},{"key":"BFnn0499_358_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-2999(96)00211-7","volume":"307","author":"LJ Sim","year":"1996","unstructured":"Sim, L. J., Selley, D. E., Xiao, R. & Childers, S. R. Differences in G-protein activation by \u03bc- and \u03b4-opioid, and cannabinoid receptors in rat striatum. Eur. J. Pharmacol. 307, 97\u2013105 (1996).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn0499_358_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0306-4522(97)00597-6","volume":"85","author":"B Szabo","year":"1998","unstructured":"Szabo, B., D\u00f6rner, L., Pfreundtner, C., N\u00f6renberg, W. & Starke, K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85, 395\u2013403 (1998).","journal-title":"Neuroscience"},{"key":"BFnn0499_358_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0304-3940(96)12436-8","volume":"206","author":"M C Sa\u00f1udo-Pe\u00f1a","year":"1996","unstructured":"Sa\u00f1udo-Pe\u00f1a, M. C., Patrick, S. L., Patrick, R. L. & Walker, J. M. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Neurosci. Lett. 206, 21\u201324 (1996).","journal-title":"Neurosci. Lett."},{"key":"BFnn0499_358_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/026988119300700411","volume":"7","author":"M Hemming","year":"1993","unstructured":"Hemming, M. & Yellowlees, P. M. Effective treatment of Tourette's syndrome with marijuana. J. Psychopharmacol. 7, 389\u2013391 (1993).","journal-title":"J. Psychopharmacol."},{"key":"BFnn0499_358_CR13","unstructured":"M\u00fcller-Vahl, K. R., Schneider, U., Kolbe, H. & Emrich, H. M. Treatment of Tourette-syndrome with delta-9-tetrahydrocannabinol. Am. J. Psychiatry (in press)."},{"key":"BFnn0499_358_CR14","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"W Devane","year":"1992","unstructured":"Devane, W. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946\u20131949 (1992).","journal-title":"Science"},{"key":"BFnn0499_358_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V Di Marzo","year":"1994","unstructured":"Di Marzo, V. et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686\u2013 691 (1994).","journal-title":"Nature"},{"key":"BFnn0499_358_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura, T. et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89\u201397 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnn0499_358_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam, R. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83\u201390 (1995).","journal-title":"Biochem. Pharmacol."},{"key":"BFnn0499_358_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/42015","volume":"388","author":"N Stella","year":"1997","unstructured":"Stella, N., Schweitzer, P. & Piomelli, D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773\u2013 778 (1997).","journal-title":"Nature"},{"key":"BFnn0499_358_CR19","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1523\/JNEUROSCI.17-04-01226.1997","volume":"17","author":"H Cadas","year":"1997","unstructured":"Cadas, H., di Tomaso, E. & Piomelli, D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17, 1226\u20131242 (1997).","journal-title":"J. Neurosci."},{"key":"BFnn0499_358_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1432-1033.1996.0053h.x","volume":"240","author":"T Sugiura","year":"1996","unstructured":"Sugiura, T. et al. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Eur. J. Biochem. 240, 53\u201362 (1996).","journal-title":"Eur. J. Biochem."},{"key":"BFnn0499_358_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/bbrc.1996.0020","volume":"218","author":"T Sugiura","year":"1996","unstructured":"Sugiura, T. et al. Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca2+-dependent transacylase and phosphodiesterase activities. Biochem. Biophys. Res. Commun. 218, 113\u2013117 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnn0499_358_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0014-5793(98)00046-5","volume":"422","author":"A Giuffrida","year":"1998","unstructured":"Giuffrida, A. & Piomelli, D. Isotope dilution GC\/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett. 422, 373\u2013376 (1998).","journal-title":"FEBS Lett."},{"key":"BFnn0499_358_CR23","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","volume":"92","author":"L Facci","year":"1995","unstructured":"Facci, L. et al. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. USA 92, 3376\u2013 3380 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn0499_358_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/28393","volume":"394","author":"A Calignano","year":"1998","unstructured":"Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature 394, 277\u2013281 (1998).","journal-title":"Nature"},{"key":"BFnn0499_358_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0009-3084(96)02554-6","volume":"80","author":"HHO Schmid","year":"1996","unstructured":"Schmid, H. H. O., Schmid, P. C. & Natarajan, V. The N-acylation-phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids 80, 133\u2013142 (1996).","journal-title":"Chem. Phys. Lipids"},{"key":"BFnn0499_358_CR26","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1074\/jbc.270.11.6030","volume":"270","author":"F Desarnaud","year":"1995","unstructured":"Desarnaud, F., Cadas, H. & Piomelli, D. Anandamide amidohydrolase activity in rat brain microsomes: identification and partial characterization. J. Biol. Chem. 270, 6030\u20136035 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnn0499_358_CR27","doi-asserted-by":"publisher","first-page":"23823","DOI":"10.1074\/jbc.270.40.23823","volume":"270","author":"N Ueda","year":"1995","unstructured":"Ueda, N., Kurahashi, Y., Yamamoto, S. & Tokunaga, T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270, 23823\u201323827 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnn0499_358_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0005-2760(95)00087-S","volume":"1257","author":"CJ Hillard","year":"1995","unstructured":"Hillard, C. J., Wilkison, D. M., Edgemont, W. S. & Campbell, W. B. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim. Biophys. Acta 1257, 249\u2013256 (1995).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnn0499_358_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt, B. F. et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83\u201387 (1996).","journal-title":"Nature"},{"key":"BFnn0499_358_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","volume":"277","author":"M Beltramo","year":"1997","unstructured":"Beltramo, M. et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 1094\u20131097 (1997).","journal-title":"Science"},{"key":"BFnn0499_358_CR31","first-page":"155","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"O Civelli","year":"1995","unstructured":"Civelli, O. in Psychopharmacology: The Fourth Generation of Progress (eds. Bloom, F. E. & Kupfer, D. J.) 155\u2013161 (Raven, New York, 1995)."},{"key":"BFnn0499_358_CR32","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S1054-3589(08)60921-7","volume":"42","author":"DJ Surmeier","year":"1998","unstructured":"Surmeier, D. J., Yan, Z. & Song, W. J. Coordinated expression of dopamine receptors in neostriatal medium spin neurons. Adv. Pharmacol. 42, 1020\u20131023 (1998).","journal-title":"Adv. Pharmacol."},{"key":"BFnn0499_358_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona, M. et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240\u2013244 (1994).","journal-title":"FEBS Lett."},{"key":"BFnn0499_358_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0014-2999(89)90837-6","volume":"161","author":"D Eilam","year":"1989","unstructured":"Eilam, D. & Szechtman, H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol. 161, 151\u2013157 (1989).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn0499_358_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0028-3908(97)00033-6","volume":"36","author":"L Thorn","year":"1997","unstructured":"Thorn, L., Ashmeade, T. E., Storey, V. J., Routledge, C. & Reavill, C. Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors. Neuropharmacology 36, 787\u2013 792 (1997).","journal-title":"Neuropharmacology"},{"key":"BFnn0499_358_CR36","first-page":"586","volume":"277","author":"DR Compton","year":"1996","unstructured":"Compton, D. R., Aceto, M. D., Lowe, J. & Martin, B. R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of \u03949-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. 277, 586\u2013594 (1996).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn0499_358_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0028-3908(78)90126-0","volume":"17","author":"AL Gough","year":"1978","unstructured":"Gough, A. L. & Olley, J. E. Catalepsy induced by intrastriatal injections of \u03949-THC and 11-OH-\u03949-THC in the rat. Neuropharmacology 17, 137\u2013 144 (1978).","journal-title":"Neuropharmacology"},{"key":"BFnn0499_358_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0091-3057(94)00396-Z","volume":"51","author":"J Souilhac","year":"1995","unstructured":"Souilhac, J., Poncelet, M., Rinaldi-Carmona, M., Le Fur, G. & Soubri\u00e9, P. Intrastriatal injection of cannabinoid receptor agonist induced turning behavior in mice. Pharmacol. Biochem. Behav. 51, 3\u20137 (1995).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnn0499_358_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0091-3057(93)90241-K","volume":"45","author":"M Navarro","year":"1993","unstructured":"Navarro, M. et al. Motor disturbances induced by an acute dose of \u03949-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations. Pharmacol. Biochem. Behav. 45, 291\u2013298 (1993).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnn0499_358_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0014-5793(98)00581-X","volume":"429","author":"S Kondo","year":"1998","unstructured":"Kondo, S. et al. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and independent mechanisms. FEBS Lett. 429, 152\u2013156 (1998).","journal-title":"FEBS Lett."},{"key":"BFnn0499_358_CR41","first-page":"989","volume":"278","author":"VM Showalter","year":"1996","unstructured":"Showalter, V. M., Compton, D. R., Martin, B. R. & Abood, M. E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 278, 989\u2013 999 (1996).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn0499_358_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1615\/CritRevNeurobiol.v11.i2-3.30","volume":"11","author":"LA Matsuda","year":"1997","unstructured":"Matsuda, L. A. Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol. 11, 143\u2013166 (1997).","journal-title":"Crit. Rev. Neurobiol."},{"key":"BFnn0499_358_CR43","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1523\/JNEUROSCI.16-12-03934.1996","volume":"16","author":"H Cadas","year":"1996","unstructured":"Cadas, H., Gaillet, S., Beltramo, M., Venance, L. & Piomelli, D. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci. 16, 3934\u20133942 (1996).","journal-title":"J. Neurosci."},{"key":"BFnn0499_358_CR44","first-page":"595","volume-title":"Psychopharmacology: The Fourth Generation of Progress","author":"D Piomelli","year":"1995","unstructured":"Piomelli, D. in Psychopharmacology: The Fourth Generation of Progress (eds. Bloom, F. E. & Kupfer, D. J.) 595\u2013607 (Raven, New York, 1995)."},{"key":"BFnn0499_358_CR45","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(97)01160-6","volume":"334","author":"RS Landsman","year":"1997","unstructured":"Landsman, R. S., Burkey, T. H., Consroe, P., Roeske, W. R. & Yamamura, H. I. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur. J. Pharmacol. 334, R1\u20132 (1997).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn0499_358_CR46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/oso\/9780198521600.003.0003","volume-title":"Neurobiology of Stereotyped Behaviour","author":"JL Waddington","year":"1990","unstructured":"Waddington, J. L., Molloy, A. G., O'Boyle, K. M. & Pugh, M. T. in Neurobiology of Stereotyped Behaviour (eds. Cooper, S. J. & Dourish, C. T.) 64\u201390 (Clarendon, Oxford, 1990)."},{"key":"BFnn0499_358_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(93)90468-W","volume":"231","author":"E Fride","year":"1993","unstructured":"Fride, E. & Mechoulam, R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231, 313\u2013314 (1993).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn0499_358_CR48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0091-3057(78)90320-9","volume":"8","author":"GT Pryor","year":"1978","unstructured":"Pryor, G. T., Larsen, F. F., Husain, S. & Braude, M. C. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats. Pharmacol. Biochem. Behav. 8, 295\u2013318 (1978).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnn0499_358_CR49","first-page":"189","volume":"8","author":"LH Parsons","year":"1994","unstructured":"Parsons, L. H. & Justice, J. B. J. Quantitative approaches to in vivo brain microdialysis. Crit. Rev. Neurobiol. 8, 189\u2013220 (1994).","journal-title":"Crit. Rev. Neurobiol."},{"key":"BFnn0499_358_CR50","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1046\/j.1471-4159.1996.67031078.x","volume":"67","author":"LH Parsons","year":"1996","unstructured":"Parsons, L. H. et al. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement. J. Neurochem. 67, 1078\u20131089 (1996).","journal-title":"J. Neurochem."}],"updated-by":[{"DOI":"10.1038\/7210","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000}}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nn0499_358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn0499_358","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn0499_358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T11:53:09Z","timestamp":1704282789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nn0499_358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["BFnn0499_358"],"URL":"https:\/\/doi.org\/10.1038\/7268","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/7210","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}